Scientists are searching for therapeutics that mimic the life-extending benefits of caloric restriction, exercise, and a good ...

By reinforcing exercise, health care providers can ensure that GLP-1 therapy leads to weight loss, sustains muscle mass, and ...

A new discovery may explain why so many people abandon cholesterol-lowering statins because of muscle pain and weakness.

"Bariatric surgery and GLP-1 receptor agonist medications are currently the most effective weight-loss interventions for ...

Megestrol, which helps treat hot flashes associated with menopause, may have the added benefit of slowing the growth of ...

Biomed Industries to Advance NA-931 Into Two Global Phase 3 Trials as Monotherapy and in Combination With Semaglutide and Tirzepatide for Obesity Advancing NA-931 into two Phase 3 programs as ...

Kirstyn Hill has worked as a clinical pediatric and women’s health pharmacist since 2020. She was driven to work with a patient population that is not often able to easily speak up for themselves and ...

Vienna — The investigational monoclonal antibody trevogrumab was associated with lean mass preservation and greater loss of fat mass in people taking semaglutide, an interim trial data showed.

1 Office of Research, Waterloo Regional Health Network, Kitchener, ON, Canada 2 Department of Oncology, Waterloo Regional Health Network, Kitchener, ON, Canada The standard of care for metastatic ...

QUEENSLAND, Australia — Antivenom can stop a mamba bite from killing you. But a new study reveals it might simply be swapping one type of paralysis for another that doctors struggle to treat.

After decades without much movement, a handful of new treatments for this rare autoimmune disease are now approved, and several companies, including argenx and Regeneron, have recently released ...